Tags Archive Navigation
icon
-
Media ReleaseNovartis investigational novel STAMP inhibitor asciminib (ABL001) meets primary endpoint of Phase III chronic myeloid leukemia study
-
Media ReleaseNovartis announces NEJM publication of pivotal study of Tabrecta™ in patients with METex14 metastatic non-small cell lung cancer
-
Interior PageChronic Myeloid Leukemia
-
Landing PageRadioligand Therapy
-
StoryA blood cancer patient’s long road to diagnosis
-
StoryThe search for new options for patients with lung cancer
-
StoryDiscover how inflammation could fan the flames of cancer
-
StoryStriving to vanquish leukemia
-
StoryResearchers boost understanding of T-cell therapy in blood cancer
-
StoryCancer research drives breast cancer treatment forward
-
StoryCan data from a heart disease trial lead to a potential cancer treatment?
-
StoryArtificial intelligence decodes cancer pathology images without image gallery
Pagination
- ‹ Previous page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- › Next page